Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for REPAGLINIDE
- PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval
- A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants
- A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants
- GLUcose Transport and REnalPROtection in Chronic Kidney Disease
- Voxelotor CYP and Transporter Cocktail Interaction Study
- A Drug Interaction Study of LY3871801 in Healthy Participants
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib
- A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants
- A Study of Imlunestrant (LY3484356) in Female Healthy Participants
- A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir
- A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer
- Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion
- Drug-drug Interaction Study of KL1333 in Healthy Subjects
- Effect of Pioglitazone on T2DM Patients With COVID-19
- A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST
- A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
- Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
- Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in
- Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Incretin-based Drugs and the Risk of Heart Failure
- The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
- A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine
- Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
- Liraglutide Hospital Discharge Trial
- A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects
- A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components
- Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
- Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes
- A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
- Efficacy of Repaglinide in Subjects With Type 2 Diabetes
- Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
- Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
- Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide
- Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
- Observational Study of NovoNorm® in Subjects With Diabetes
- An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers
- Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes
- Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea
- An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients
- Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment
- Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers
- Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions
- Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs
- Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
- Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
- Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
- Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes
- Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
- Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
- Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes
- Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs
- Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
- A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
- Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
- Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet
- Diabetes Therapy to Improve BMI and Lung Function in CF
Clinical trials list
click for details